natalizumab
biogen
['natalizumab']
schneider-hohendorf: in blood of ms pts they found a broader ebv-specific t-cell receptor profile and evidence of ongoing ebv response causing continuous egress of ebv-specific cells from bood to tissue (in a natalizumab treated cohort).
#ectrims2022 
Professor Dr Bart Van Wijmeersch
Neurologist, Immunologist
#MultipleSclerosis Expert
@ University MS Centre, Hasselt-Pelt, Belgium